Wednesday, August 15, 2018

Sun Pharma Q1 review: All eyes on the speciality business

Sun Pharma Q1 review: All eyes on the speciality business We continue to like the strong domestic business of Sun and the niche that it is trying to create with speciality in the US.

from Moneycontrol Business News https://ift.tt/2nFPYGt

No comments:

Post a Comment

Bitcoin stays near $64K, Ethereum underperforms as weak risk appetite keeps crypto markets under pressure

Bitcoin traded near $64,000 and Ethereum underperformed as risk appetite weakened. The global crypto market capitalization edged down 2% to ...